The estimated Net Worth of Thomas C Lavoy is at least $121 Tisíc dollars as of 1 March 2018. Thomas Lavoy owns over 50,000 units of Perspective Therapeutics Inc stock worth over $121,472 and over the last 17 years Thomas sold ISR stock worth over $0.
Thomas has made over 9 trades of the Perspective Therapeutics Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently Thomas bought 50,000 units of ISR stock worth $22,000 on 1 March 2018.
The largest trade Thomas's ever made was exercising 82,810 units of Perspective Therapeutics Inc stock on 20 November 2017 worth over $50,514. On average, Thomas trades about 18,394 units every 163 days since 2007. As of 1 March 2018 Thomas still owns at least 316,333 units of Perspective Therapeutics Inc stock.
You can see the complete history of Thomas Lavoy stock trades at the bottom of the page.
Thomas's mailing address filed with the SEC is C/O SUPERSHUTTLE INTERNATIONAL INC, 14500 N. NORTHSIGHT BLVD., SUITE 329, SCOTTSDALE, AZ, 85260.
Over the last 18 years, insiders at Perspective Therapeutics Inc have traded over $0 worth of Perspective Therapeutics Inc stock and bought 1,651,741 units worth $855,397 . The most active insiders traders include Lori A Woods, Thomas C Lavoy a Dwight William Babcock. On average, Perspective Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $14,501. The most recent stock trade was executed by Lori A Woods on 13 April 2023, trading 187,500 units of ISR stock currently worth $114,375.
Isoray, Inc., through its subsidiary, Isoray Medical, Inc., is the sole producer of Cesium Blu brachytherapy seeds, which are expanding brachytherapy treatment options throughout the body.
Perspective Therapeutics Inc executives and other stock owners filed with the SEC include: